The new rules for personal finances
April 15th 2009The upheaval in our current economy is changing the ground rules for skillful handling of personal finances. Some of the time-honored methods for building and maintaining a secure financial future for you and your family need to be modified while today's unpredictable financial crisis runs its course. Here are seven tips from the experts that will help you to come out on top once the financial storm has abated.
Read More
Alternative minimum tax expected to affect more U.S. taxpayers
March 1st 2006For those in the know, the AMT has become the tax equivalent of the boogeyman. Unfortunately, unlike the object of children's nightmares, this lurking threat is all too real. Calculated alongside ordinary income tax for all households, the AMT erases many standard deductions to which Americans have become accustomed. Taxpayers then must pay whichever tax is higher.
Read More
View from 'shoulders of giants' offers new vision
January 1st 2006The president, president-elect, and executive vice president of the American Academy of Ophthalmology (AAO) recently offered a "state-of-the-profession" message during the opening session of the AAO annual meeting in Chicago. All three executives shared in a celebration of past achievements, current conditions, and future opportunities in ophthalmology
Read More
Alimera Sciences fulfills unmet eye-care needs
October 15th 2005Alpharetta, GA—When the global management of Novartis decided to shut down its ophthalmic operations in Duluth, GA, in early 2003 and relocate to New Jersey, Dan Myers, then president of Novartis Ophthalmics/North America, thought he would leave the company and have the next 6 months to relax.
Read More
Intravitreal triamcinolone helps macular diseases
October 1st 2005Montreal—Intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) is effective in the treatment of macular diseases but is associated with complications such as ocular hypertension, endophthalmitis, intraocular inflammation, and progression of cataract. While the long-term effects of the drug still need to be determined, the drug appears to be safe for treating macular diseases.
Read More